Pharmacist‑led programs consistently improve adherence, capture adverse events earlier, and reduce avoidable delays. Here’s a blueprint to start small and scale.
Pick one tumor type and one oral regimen with meaningful volume. Define inclusion criteria and a 60–90 day window. Your goal is to prove feasibility and generate early outcomes you can share with clinicians and administrators.
Create a counseling checklist that covers indication, dosing, missed doses, storage, drug interactions, and red‑flag symptoms. Provide written and digital take‑home materials. Log completion in the EHR with a smartphrase or template.
Use a 7–14 day check‑in after therapy start, then touchpoints aligned to refills. Capture adherence (possession ratio + self‑report), toxicities (CTCAE terms where practical), and lab results if indicated. Route issues to the care team with clear escalation paths.
Integrate prior authorization steps and financial navigation. Synchronize refills where possible to reduce gaps, and track days of therapy on hand to anticipate lapses.
Package your SOPs, patient materials, and documentation templates. Train pharmacists, nurses, and front‑desk staff on the workflow and escalation policies. Review data monthly and iterate.